1. Home
  2. INSM vs USFD Comparison

INSM vs USFD Comparison

Compare INSM & USFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • USFD
  • Stock Information
  • Founded
  • INSM 1988
  • USFD 2007
  • Country
  • INSM United States
  • USFD United States
  • Employees
  • INSM N/A
  • USFD N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • USFD Food Distributors
  • Sector
  • INSM Health Care
  • USFD Consumer Discretionary
  • Exchange
  • INSM Nasdaq
  • USFD Nasdaq
  • Market Cap
  • INSM 12.6B
  • USFD 15.1B
  • IPO Year
  • INSM 2000
  • USFD 2016
  • Fundamental
  • Price
  • INSM $69.73
  • USFD $79.13
  • Analyst Decision
  • INSM Strong Buy
  • USFD Strong Buy
  • Analyst Count
  • INSM 17
  • USFD 11
  • Target Price
  • INSM $95.93
  • USFD $81.73
  • AVG Volume (30 Days)
  • INSM 2.3M
  • USFD 2.5M
  • Earning Date
  • INSM 05-08-2025
  • USFD 05-08-2025
  • Dividend Yield
  • INSM N/A
  • USFD N/A
  • EPS Growth
  • INSM N/A
  • USFD 7.60
  • EPS
  • INSM N/A
  • USFD 2.19
  • Revenue
  • INSM $381,030,000.00
  • USFD $38,279,000,000.00
  • Revenue This Year
  • INSM $29.15
  • USFD $7.14
  • Revenue Next Year
  • INSM $115.02
  • USFD $5.89
  • P/E Ratio
  • INSM N/A
  • USFD $36.20
  • Revenue Growth
  • INSM 20.77
  • USFD 6.32
  • 52 Week Low
  • INSM $53.69
  • USFD $50.05
  • 52 Week High
  • INSM $84.91
  • USFD $79.64
  • Technical
  • Relative Strength Index (RSI)
  • INSM 53.15
  • USFD 76.02
  • Support Level
  • INSM $65.56
  • USFD $75.20
  • Resistance Level
  • INSM $68.74
  • USFD $78.18
  • Average True Range (ATR)
  • INSM 2.41
  • USFD 1.41
  • MACD
  • INSM 0.42
  • USFD 0.16
  • Stochastic Oscillator
  • INSM 76.91
  • USFD 92.89

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About USFD US Foods Holding Corp.

US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.

Share on Social Networks: